Genetic variations and polymorphisms of G protein-coupled receptors: Functional and therapeutic implications

被引:74
作者
Rana, BK [1 ]
Shiina, T [1 ]
Insel, PA [1 ]
机构
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
关键词
SNPs; variants; mutants; structure-function; complex diseases;
D O I
10.1146/annurev.pharmtox.41.1.593
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs) represent a major class of proteins in the genome of many species, including humans. In addition to the mapping of a number of human disorders to regions of the genome containing GPCRs, a growing body of literature has documented frequently occurring variations (i.e. polymorphisms) in GPCR loci. In this article, we use a domain-based approach to systematically examine examples of genetic variation in the coding and noncoding regions of GPCR loci. Data to date indicate that residues in GPCRs are involved in ligand binding and coupling to G proteins and that regulation can be altered by polymorphisms. Studies of GPCR polymorphisms have also uncovered the functional importance of residues not previously implicated from other approaches that are involved in the function of GPCRs. We predict that studies of GPCR polymorphisms will have a significant impact on medicine and pharmacology, in particular, by providing new means to subclassify patients in terms of both diagnosis and treatment.
引用
收藏
页码:593 / 624
页数:34
相关论文
共 153 条
[41]  
2-2
[42]   NO STRUCTURAL MUTATION IN THE DOPAMINE-D2 RECEPTOR GENE IN ALCOHOLISM OR SCHIZOPHRENIA - ANALYSIS USING DENATURING GRADIENT GEL-ELECTROPHORESIS [J].
GEJMAN, PV ;
RAM, A ;
GELERNTER, J ;
FRIEDMAN, E ;
CAO, QH ;
PICKAR, D ;
BLUM, K ;
NOBLE, EP ;
KRANZLER, HR ;
OMALLEY, S ;
HAMER, DH ;
WHITSITT, F ;
RAO, P ;
DELISI, LE ;
VIRKKUNEN, M ;
LINNOILA, M ;
GOLDMAN, D ;
GERSHON, ES .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :204-208
[43]  
GEORGE ST, 1986, J BIOL CHEM, V261, P6559
[44]  
GERTHER U, 1998, J BIOL CHEM, V273, P17979
[45]   Uncovering molecular mechanisms involved in activation of G protein-coupled receptors [J].
Gether, U .
ENDOCRINE REVIEWS, 2000, 21 (01) :90-113
[46]   CLONING OF THE CDNA AND GENE FOR A HUMAN D2-DOPAMINE RECEPTOR [J].
GRANDY, DK ;
MARCHIONNI, MA ;
MAKAM, H ;
STOFKO, RE ;
ALFANO, M ;
FROTHINGHAM, L ;
FISCHER, JB ;
BURKEHOWIE, KJ ;
BUNZOW, JR ;
SERVER, AC ;
CIVELLI, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9762-9766
[47]   β-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians [J].
Gratze, G ;
Fortin, J ;
Labugger, R ;
Binder, A ;
Kotanko, P ;
Timmermann, B ;
Luft, FC ;
Hoehe, MR ;
Skrabal, F .
HYPERTENSION, 1999, 33 (06) :1425-1430
[48]   AMINO-TERMINAL POLYMORPHISMS OF THE HUMAN BETA(2)-ADRENERGIC RECEPTOR IMPART DISTINCT AGONIST-PROMOTED REGULATORY PROPERTIES [J].
GREEN, SA ;
TURKI, J ;
INNIS, M ;
LIGGETT, SB .
BIOCHEMISTRY, 1994, 33 (32) :9414-9419
[49]   Association of CCR5 del32 with reduced risk of asthma [J].
Hall, IP ;
Wheatley, A ;
Christie, G ;
McDougall, C ;
Hubbard, R ;
Helms, PJ .
LANCET, 1999, 354 (9186) :1264-1265
[50]   A peptide derived from a beta(2)-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation [J].
Hebert, TE ;
Moffett, S ;
Morello, JP ;
Loisel, TP ;
Bichet, DG ;
Barret, C ;
Bouvier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) :16384-16392